Dynamics of transgene expression in human glioblastoma cells mediated by herpes simplex virus/adeno-associated virus amplicon vectors

Human Gene Therapy

Volumn 13, Issue 18, 2002, Pages 2147-2159

  Lam, Paula ^a,b   Hui, Kam M ^b   Wang, Yaming ^c   Allen, Paul D ^c   Louis, David N ^a   Yuan, C J ^b   Breakefield, Xandra O ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HELICASE; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ALLELE; AMPLICON; ARTICLE; CELL SELECTION; CHROMOSOME 19Q; CONTROLLED STUDY; GENE EXPRESSION; GENE THERAPY; GLIOBLASTOMA; HERPES SIMPLEX VIRUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; INVERTED TERMINAL REPEAT; LONG TERMINAL REPEAT; TRANSGENE;

DEPENDOVIRUS; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; GLIOBLASTOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; SIMPLEXVIRUS; TRANSGENES; TUMOR CELLS, CULTURED;

ADENO-ASSOCIATED VIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 1; INSERTION SEQUENCES; SIMPLEXVIRUS;

EID: 0347367057     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303402320987842     Document Type: Article

References (70)

1. BALAGUE, C., KALLA, M., and ZHANG, W.W. (1997). Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J. Virol. 71, 3299-3306.
2. BERNS, K.I., and LINDEN, R.M. (1995). The cryptic life style of adeno-associated virus. Bioessays 17, 237-245.
3. BRISTER, J.R., and MUZYCZKA, N. (2000). Mechanism of Rep-mediated adeno-associated virus origin nicking. J. Virol. 74, 7762-7771.
4. CHEJANOVSKY, N., and CARTER, B.J. (1989). Mutagenesis of an AUG codon in the adeno-associated virus rep gene: Effects on viral DNA replication. Virology 126, 505-516.
5. CHERNOVA, O., and COWELL, J.K. (1998). Molecular definition of chromosome translocations involving 10q24 and 19q13 in human malignant glioma cells. Cancer Genet. Cytogenet. 105, 60-68.
6. CHIORINI, J.A., WEITZMAN, M.D., OWENS, R.A., URCELAY, E., SAFER, B., and KOTIN, R.M. (1994a). Biologically active Rep proteins of adeno-associated virus type 2 produced as fusion proteins in Escherichia coli. J. Virol. 68, 797-804.
7. CHIORINI, J.A., WIENER, S.M., OWENS, R.A., KYOSTIO, S.R., KOTIN, R.M., and SAFER, B. (1994b). Sequence requirements for stable binding and function of Rep68 on the adeno-associated virus type 2 inverted terminal repeats. J. Virol. 68, 7448-7457.
8. CHIORINI, J.A., AFIONE, S., and KOTIN, R.M. (1999). Adeno-associated virus (AAV) type 5 Rep protein cleaves a unique terminal resolution site compared with other AAV stereotypes. J. Virol. 73, 4293-4298.
9. CUNNINGHAM, C., and DAVISON, A.J. (1993). A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology 197, 116-124.
10. FLOTTE, T.R., SOLOW, R., OWENS, R.A., AFIONE, S., ZEITLIN, P.L., and CARTER, B.J. (1992). Gene expression from adeno-associated virus vector in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 7, 349-356.
11. FLOTTE, T.R., AFIONE, S.A., SOLOW, R., DRUMM, M.L., MARKAKIS, D., GUGGINO, W.B., ZEITLIN, P.L., and CARTER, B.J. (1993). Expression of the cystic fibrosis transmembrane conductance regulator for a novel adeno-associated virus promoter. J. Biol. Chem. 268, 3781-3790.
12. FRAEFEL, C., SONG, S., LIM, F., LANG, P., YU, L., WANG, Y., WILD, P., and GELLER, A. (1996). Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol. 70, 7190-7197.
13. FU, Y., WANG, Y., and EVANS, S.M. (1998). Viral sequences enable efficient and tissue-specific expression of transgenes in Xenopus. Nat. Biotech. 16, 253-257.
14. FURNARI, F.B., LIN, H., HUANG, H.S., and CAVENEE, W.K. (1997). Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc. Natl. Acad. Sci. U.S.A. 94, 12479-12484.
15. GELLER, A.I., KEYOMARSI, K., BRYAN, J., and PARDEE, A.B. (1990). An efficient deletion mutant packaging system for defective herpes simplex virus vectors: Potential applications to human gene therapy and neuronal physiology. Proc. Natl. Acad. Sci. U.S.A. 87, 8950-8954.
16. GOTTLIEB, J., and MUZYCZKA, N. (1988). In vitro excision of adeno-associated virus DNA from recombinant plasmids: Isolation of an enzyme fraction from HeLa cells that cleaves DNA at poly(G) sequences. Mol. Cell Biol. 8, 2513-2522.
17. HAMPL, J., CAMP, S., MYDLARZ, W., HAMPL, M., ISHIKAWA, T., CHIOCCA, E.A., LOUIS, D., SENA-ESTEVES, M., and BREAKEFIELD, X.O. (2002). Potentiated gene delivery to tumors using HSV/EBV/RV tribrid amplicon vectors. (In preparation).
18. HAUSWIRTH, W.W., and BERNS, K.I. (1979). Adeno-associated virus DNA replication: Nonunit-length molecules. Virology 93, 57-68.
19. HEISTER, T., HELD, I., ACKERMANN, M., and FRAEFEL, C. (2002). Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19. J. Virol. 76, 7163-7173.
20. HOI SANG, U., ESPIRITU, O.D., KELLEY, P.Y., KLAUBER, M.R., and HATTON, J.D. (1995). The role of the epidermal growth factor receptor in human gliomas. II. The control of glial process extension and the expression of glial fibrillary acidic protein. J. Neurosurg. 82, 847-857.
21. HSIAO, C.D., HSIEH, F.J., and TSAI, H.J. (2001). Enhanced expression and stable transmission of transgenes flanked by inverted terminal repeats from adeno-associated virus in zebrafish. Dev. Dyn. 220, 323-336.
22. IM, D.S., and MUZYCZKA, N. (1990). The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell 61, 447-457.
23. ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol. 9, 467-479.
24. JACOBS, A., BREAKEFIELD, X.O., and FRAEFEL, C. (1999). HSV-1 based vectors for gene therapy of neurological diseases and brain tumors. II. Vector systems and applications. Neoplasia 5, 402-416.
25. JOHNSTON, K.M., JACOBY, D., PECHAN, P., FRAEFEL, C., BORGHESANI, P., SCHUBACK, D., DUNN, R., SMITH, F., and BREAKEFIELD, X.O. (1997). HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum. Gene Ther. 8, 359-370.
26. KEARNS, W.G., AFIONE, S.A., FULMER, S.B., PANG, M.G., ERIKSON, D., EGAN, M., LANDRUM, M.J., FLOTTE, T.R., and CUTTING, G.R. (1996). Recombinant adenoassociated (AAV-CTFR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther. 3, 748-755.
27. KOTIN, R.M., and BERNS, K.I. (1989). Organization of adeno-associated virus DNA in latently infected Detroit 6 cells. Virology 170, 460-467.
28. KOTIN, R.M., SINSCALCO, M., SAMULSKI, R.J., ZHU, X., HUNTER, L., LAUGHLIN, C.A., MCLAUGHLIN, S, MUZYCZKA, N., ROCCHI, M., and BERNS, K.I. (1990). Site-specific integration of adeno-associated virus. Proc. Natl. Acad. Sci. U.S.A. 87, 2211-2215.
29. KOTIN, R.M., LINDEN, R.M., and BERNS, K.I. (1992). Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11, 5071-5078.
30. LAM, P.Y., and BREAKEFIELD, X.O. (2000). Hybrid vector designs to control the delivery, fate and expression of transgenes. J. Gene Med. 2, 395-408.
31. LAMMERING, G., LIN, P.S., CONTESSA, J.N., HAMPTON, J.L., VALERIE, K., and SCHMIDT-ULLRICH, R.K. (2001). Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells. Int. J. Radiat. Oncol. Biol. Phys. 51, 775-784.
32. LINDEN, R.M., and BERNS, K.I. (1997). Site-specific integration by adeno-associated virus: A basis for a potential gene therapy vector. Gene Ther. 4, 4-5.
33. LINDEN, R.M., WINOCOUR, E., and BERNS, K.I. (1996). The recombination signals for adeno-associated virus site-specific integration. Proc. Natl. Acad. Sci. U.S.A. 93, 7966-7972.
34. MCCARTY, D.M., PEREIRA, D.J., ZOLOTUKHIN, S., ZHOU, X., RYAN, J.H., and MUZYCZKA, N. (1994). Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein. J. Virol. 68, 4988-4997.
35. MCLAUGHLIN, S.K., COLLIS, P., HERMONAT, P.L., and MUZYCKA, N. (1988). Adeno-associated virus general transduction vectors: Analysis of proviral structures. J. Virol. 62, 1963-1973.
36. MIAO, C.H., SNYDER, R.O., and SCHOWALTER, D.B., (1998). The kinetics of rAAV integration in the liver. Nat. Genet. 19, 13-15.
37. MUZYCZKA, N. (1991). In vitro replication of adeno-associated virus DNA. Semin. Virol. 2, 281-290.
38. NAGANE, M., COUFAL, F., LIN, H., BOGLER, O., CAVENEE, W.K., and HUANG, H.J. (1996). A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res. 56, 5079-5086.
39. NISHIKAWA, R., JI, X.D., HARMON, R.C., LAZAR, C.S., GILL, G.N., CAVENEE, W.K., and HUANG, H.J. (1994). A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl. Acad. Sci. U.S.A. 91, 7727-7731.
40. OWENS, R.A., WEITZMAN, M.D., KYOSTIO, S.R., and CARTER, B.J. (1993). Identification of a DNA-binding domain in the amino terminus of adeno-associated virus Rep proteins. J. Virol. 67, 997-1005.
41. PHILIP, R., BRUNETTE, E., KILINSKI, L., MURUGESH, D., MCNALLY, M.A., UCAR, K., ROSENBLATT, J., OKARMA, T.B., and LEBKOWSKI, J.S. (1994). Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. Mol. Cell Biol. 14, 2411-2418.
42. PONNAZHAGAN,.S., ERIKSON, D, KEARNS, W.G., ZHOU, S.Z., NAHREINI, P., WANG, X.S., and SRIVASTAVA, A. (1997). Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. Hum. Gene Ther. 8, 275-284.
43. ROSENBERG, J.E., LISLE, D.K., BURWICK, J.A., UEKI, K., VON DEIMLING, A., MOHRENWEISER, H.W., and LOUIS, D.N. (1996). Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval. Oncogene 13, 2483-2485.
44. RUTLEDGE, E.A., and RUSSELL, D.W. (1997). Adeno-associated virus vector integration junctions. J. Virol. 71, 8429-8436.
45. RYAN, J.H., ZOLOTUKHIN, S., and MUZYCZKA, N. (1996). Sequence requirements for binding of Rep68 to the adeno-associated virus terminal repeats. J. Virol. 70, 1542-1553.
46. SAEKI, Y., ICHIKAWA, T., SAEKI, A., CHIOCCA, E.A., TOBLER, K., ACKERMANN, M., BREAKEFIELD, X.O., and FRAEFEL, C. (1998). Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: Rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum. Gene Ther. 9, 2787-2794.
47. SAEKI, Y., FRAEFEL, C., ICHIKAWA, T., BREAKEFIELD, X.O., and CHIOCCA, E.A. (2001). Improved helper virus-free packaging. HSV amplicon vectors using an ICP27-deleted oversized HSV-1 DNA in a bacterial artificial chromosome. Mol. Ther. 3, 591-601.
48. SAMBROOK, J., FRITSCH, E.F., and MANIATIS, T. (1989). Molecular Cloning. A Laboratory Manual. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY).
49. SAMULSKI, R.J., CHANG, L.S., and SHENK, T. (1987). A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J. Virol. 61, 3096-3101.
50. SAMULSKI, R.J., ZHU, X., XIAO, X., BROOK, J.D., HOUSMAN, D.E., EPSTEIN, N., and HUNTER, L.A. (1991). Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10, 3941-3950.
51. SENA-ESTEVES, M., SAEKI, Y., CAMP, S., CHIOCCA, E.A., and BREAKEFIELD, X.O. (1999). Single step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein Barr virus hybrid amplicons. J. Virol. 73, 10426-10439.
52. SENA-ESTEVES, M., SAEKI, Y., FRAEFEL, C., and BREAKEFIELD, X.O. (2000). HSV-1 amplicon vectors: Simplicity and versatility. Mol. Ther. 2, 9-15.
53. SMITH, I.L., HARDWICKE, M., and SANDRI-GOLDIN, R.M. (1992). Evidence that the herpes simplex virus immediate protein ICP27 acts post-transcriptionally during infection to regulate gene expression. Virology 186, 74-86.
54. SNYDER, R.O., IM, D.S., NI, T., XIAO, X., SAMULSKI, R.J., and MUZYCZKA, N. (1993). Features of the adeno-associated virus origin involved in substrate recognition by the viral Rep protein. J. Virol. 67, 6096-6104.
55. SPAETE, R., and FRENKEL, N. (1982). The herpes virus amplicon: A new eucaryotic defective-virus cloning-amplifying vector. Cell 30, 295-304.
56. STAVROPOULOS, T.A., and STRATHDEE, C.A. (1998). An enhanced packaging system for helper-dependent herpes simplex virus vectors. J. Virol. 72, 7137-7143.
57. SUROSKY, R.T., URABE, M., GODWIN, S.G., MCQUISTON, S.A., KURTZMAN, G.J., OZAWA, K., and NATSOULIS, G. (1997). Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J. Virol. 71, 7951-7959.
58. URCELAY, E., WARD, P., WIENER, S.M., SAFER, B., and KOTIN, R.M. (1995). Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein. J. Virol. 69, 2038-2046.
59. WADE-MARTINS, R., SMITH, E.R., TYMINSKI, E., CHIOCCA, E.A., and SAEKI, Y. (2001). An infectious transfer and expression system for genomic DNA loci in human and mouse cells. Nat. Biotechnol. 19, 1067-1070.
60. WANG, X.S., PONNAZHAGAN, S., and SRIVASTAVA, A. (1995). Rescue and replication signals of the adeno-associated virus 2 genome. J. Mol. Biol. 250, 573-580.
61. WANG, X.S., PONNAZHAGAN, S., and SRIVASTAVA, A. (1996). Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences in recombinant plasmids containing deletions in the viral inverted terminal repeats: Selective encapsidation of viral genomes in progeny virions. J. Virol. 70, 1668-1677.
62. WANG, X.S., QING, K., PONNAZHAGAN, S., and SRIVASTAVA, A. (1997). Adeno-associated virus type 2 DNA replication in vivo: Mutation analyses of the D sequence in viral inverted terminal repeats. J. Virol. 71, 3077-3082.
63. WANG, S., DI, S., YOUNG, W.-B., JACOBSON, C., and LINK, C.J., Jr. (1997). A novel herpesvirus amplicon system for in vivo gene delivery. Gene Ther. 4, 1132-1141.
64. WANG, Y., FRAEFEL, C., PROTASI, F., MOORE, R.A., FESSENDEN, J.D., PESSAH, I.N., DIFRANCESCA, A., BREAKEFIELD, X.O., and ALLEN, P.D. (2000). HSV-1 amplicon vectors are a highly efficient gene delivery system for skeletal muscle myoblasts and myotubes. Am. J. Physiol. Cell Physiol. 278, C619-C626.
65. + hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration. J. Virol. 76, 7150-7162.
66. WEITZMAN, M.D., KYOSTIO, S.R.M., KOTIN, R.M., and OWENS, R.A. (1994). Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA. Proc. Natl. Acad. Sci. U.S.A. 91, 5808-5812.
67. WOLFE, D., GOINS, W.F., YAMADA, M., MORIUCHI, S., KRISKY, D.M., OLIGINO, T.J., MARCONI, P.C., FINK, D.J., and GLORIOSO, J.C. (1999). Engineering herpes simplex virus vectors for CNS applications. Exp. Neurol. 159, 34-46.
68. XIAO, X., XIAO, W., LI, J., and SAMULSKI, R.J. (1997). A novel 165-base-pair terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle. J. Virol. 71, 941-948.
69. YANG, C.C., XIAO, X., ZHU, X., ANSARDI, D.C., EPSTEIN, N.D., FREY, M.R., MATERA, A.G., and SAMULSKI, R.J. (1997). Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro. J. Virol. 71, 9231-9247.
70. YANG, Q., CHEN, F., and TREMPE, J.P. (1994). Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins. J. Virol. 68, 4847-4856.